By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug Administration granted regular approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) for
As part of our series of interviews with the 2022 Binaytara Foundation (BTF) award winners who are improving access to cancer care, today we talk with Dr. Bhawna Sirohi, winner of the
More
In this blog article, Dr. Dan Milner, Chief Medical Officer of the American Society for Clinical Pathology, discusses his experience about his participation in the 2022 Summit on Cancer Health Disparities held
More
Jody Stroh is the Binaytara Foundation's 2022 Volunteer of the Year.
More
Janakpurdham, Nepal, April 17, 2022 – The Binaytara Cancer Trust (the non-profit organization that operates the Binaytara Foundation Cancer Center) held a Supporter’s Dinner on April 15 to thank the donors, supporters,
More
Janakpurdham, Nepal, April 16, 2022 – The Binaytara Cancer Trust held a groundbreaking ceremony for the first phase of its planned 200-bed cancer hospital in Janakpurdham, Nepal on April 15. The Binaytara
More
For more information contact: Tara Shah (425) 557-5953 [email protected] April 1, 2022, Janakpurdham, Nepal – The Binaytara Foundation Cancer Center (BTFCC) is pleased to welcome Dr. Rubina Suwal, who will perform head
More